{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-149590","form_type":"8-K","ticker":"GRTX","cik":"0001563577","company_name":"Galera Therapeutics, Inc.","filed_at":"2026-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.473939+00:00","generated_at":"2026-05-15T06:47:18.941224+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Galera converts 76.5K Series B preferred into 76.5M common shares; warrants exercised","bullets":["Converted 76,479.175 Series B Preferred shares into 76,479,164 common shares on April 7, 2026.","After conversion, 42,839.11 Series B Preferred shares remain outstanding.","Ikarian Capital affiliates exercised pre-funded warrants for 8,488,229 common shares at $0.001/share on April 8, 2026.","Remaining pre-funded warrants to purchase 14,552,811 common shares outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-149590","json":"https://secwatch.observer/filing/0001193125-26-149590.json","markdown":"https://secwatch.observer/filing/0001193125-26-149590.md","text":"https://secwatch.observer/filing/0001193125-26-149590.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526149590/0001193125-26-149590-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526149590/d136871d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:47:18.941224+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}